NASH Observatory

⏿ The PanNASH Initiative is an interactive web-based platform presenting global NASH statistics to inform NASH control and research.

NAFLD/NASH as a metabolic disease: improving patients outcomes

Prof. Maarten Tushuizen, Netherlands, discusses the current treatment strategies for non-alcoholic fatty liver disease (NAFLD) and explains as well as future therapeutic approaches. Non-invasive tests (NITs) for staging the continuum of NAFLD / NASH are critical as well as establishing effective care pathways.

Read MoreNAFLD/NASH as a metabolic disease: improving patients outcomes

Hepatic fibrosis and CV risk factors: the Framingham Heart Study

Although liver fat is associated with cardiovascular risk factors, the association between hepatic fibrosis and cardiovascular risk factors is less clear. M. T. Long et al. (Boston University School of Medicine, USA) performed vibration-controlled transient elastography, assessing controlled attenuation parameter...
Read MoreHepatic fibrosis and CV risk factors: the Framingham Heart Study